Effect of Edaravone in prevention of contrast-induced acute kidney injury (CI-AKI)
Phase 3
Recruiting
- Conditions
- Contrast induced nephropathy acute kidney injury (CIN-AKI).Other injury of kidneyS37.09
- Registration Number
- IRCT20201108049311N5
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Candidates for coronary angiography
Patients with kidney injury stage 4 and Stage 3B with GFR between 15 and 45
Patients with underlying diseases such as diabetes and lupus that cause renal failure
Exclusion Criteria
Pregnancy
lactation
Age over than 75 years
5-fold increased liver enzymes
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum creatinine level. Timepoint: Day 5 of contrast injection. Method of measurement: Biochemical methods.;Hospitalization duration. Timepoint: Number of hospitalization days after angiography. Method of measurement: Patients' documents.
- Secondary Outcome Measures
Name Time Method